Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: GlobalData
$125.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cancer Genetics Inc Announces Closing of Public Offering of Shares of Common Stock


Monday, 28 Oct 2013 04:10pm EDT 

Cancer Genetics Inc announced the closing of its previously announced public offering of 3,286,700 shares of its common stock (including 428,700 shares that were offered and sold by Cancer Genetics pursuant to the exercise in full of the underwriters' over-allotment option) at a price to the public of $14.00 per share. The gross proceeds to Cancer Genetics from the offering were $46 million, before underwriting discounts and commissions and other offering expenses payable by Cancer Genetics. 

Company Quote

9.19
-0.05 -0.54%
4:00pm EDT